Register for our free email digests:
Division of Boston Scientific Corp.
Latest From Abbott Point of Care
Questions on how to decontaminate laboratory analyzers are coming into the Centers for Disease Control and Prevention as U.S. laboratories prepare to accept suspected Ebola specimens, an official says.
Derived from Strategic Transactions, EBI’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment –In Vitro Diagnostics, Medical Devices, and Pharmaceuticals– and then categorized by type –Acquisition, Alliance, or Financing.
A roundup of recent medtech mergers & acquisitions, strategic alliances, and financings.
- Implantable Devices
Surgical Equipment & Devices
- Minimally or Less Invasive
- Therapeutic Areas
- Neurology, Nervous System
- North America
- Parent & Subsidiaries
- Boston Scientific Corp.
- Senior Management
Brad Swatfager, CFO
Gregg Sutton, VP, R&D
Maggie Wallner, VP, Mktg.
- Contact Info
Phone: (763) 746-5012
3750 Annapolis Ln.
Plymouth, MN 55457
You must sign in to use this functionality
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.